MIT Lincoln Labratory

Quanterix Corporation, based in Lexington, MA, is a leading provider of ultrasensitive biomarker detection technology and precision instruments for the healthcare industry. Their Simoa technology enables researchers to detect biomarkers at lower levels than ever before, revolutionizing disease detection, prognosis, and treatment methods. With a wide range of assay kits, custom assay development services, and advanced instruments, Quanterix empowers researchers to make breakthrough discoveries in neurology, oncology, immunology, inflammation, infectious diseases, and cardiology. By applying precision science to the biology of health and disease, Quanterix is at the forefront of scientific advancements in multiple therapeutic areas. Their Simoa technology has been featured in hundreds of peer-reviewed publications, demonstrating its impact in fields such as oncology, neurology, cardiology, inflammation, and infectious diseases. With their commitment to catalyzing scientific research, Quanterix is driving innovation and transforming the future of healthcare.Generated from the website